Welcome to our dedicated page for Integer Hldgs news (Ticker: ITGR), a resource for investors and traders seeking the latest updates and insights on Integer Hldgs stock.
Integer Holdings Corporation (NYSE: ITGR) is a medical device contract development and manufacturing organization (CDMO) that regularly issues news on its operations, financial performance, and corporate developments. The company focuses on serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets, and its updates reflect activity across these areas.
On this page, readers can follow ITGR news related to quarterly earnings, product line performance, and outlooks that Integer provides through press releases furnished with Form 8-K filings. These releases often include discussions of sales trends in Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Other Markets, along with non-GAAP financial measures such as adjusted operating income, adjusted EBITDA, adjusted net income, and adjusted earnings per share.
Integer’s news flow also covers strategic and governance events, such as leadership transitions, board appointments, and capital allocation decisions. Recent examples include the appointment of a new President and Chief Executive Officer, the election of a new director with extensive medical device industry experience, and the authorization of a share repurchase program by the Board of Directors.
In addition, Integer publishes updates on technology and market-facing activities, such as participation in medical society meetings and healthcare investor conferences. The company has highlighted innovations in neuromodulation and miniaturized active implantable medical devices, including high-performance batteries and integrated implantable pulse generator and lead systems, as well as its Xcellion Gen 3 fast charge lithium ion battery technology.
Investors and observers can use this news page to monitor how Integer communicates its strategy, product line dynamics, financing actions, and role as a CDMO in the cardiac rhythm management, neuromodulation, and cardio and vascular markets.
Integer Holdings Corporation (ITGR) has successfully acquired Oscor, Inc., enhancing its portfolio in cardiovascular and neurostimulation markets. This acquisition adds specialized medical devices including venous access systems and diagnostic catheters, expanding Integer's product offerings and low-cost manufacturing capacity in the Dominican Republic. The deal is expected to strengthen customer relationships and foster growth through increased R&D capabilities. Oscor, with a legacy of over 40 years in electrophysiology, will significantly enhance Integer's market presence.
Integer Holdings Corporation (NYSE:ITGR) reported a 30% increase in sales for Q3 2021, reaching $306 million. However, GAAP net income fell 27% to $22 million, while non-GAAP adjusted net income surged 109% to $35 million. The company announced the acquisition of Oscor, Inc. for $220 million, which is expected to close in December 2021, enhancing Integer’s product offerings. 2021 sales outlook has been raised, projecting 12% to 14% growth. Integer aims for $200 to $250 million in annual capital for strategic acquisitions.
Integer Holdings Corporation (NYSE:ITGR) will release its Q3 2021 financial and operational results on October 28, 2021, at 7 a.m. CT. A conference call will follow at 8 a.m. CT to discuss these results and any significant forward-looking information. The call can be accessed via domestic and international numbers, with a conference ID of 7357789. An audio replay will be available for seven days post-call. Integer is a leading medical device outsource manufacturer, with a focus on cardiac and neuromodulation technologies.
Integer Holdings Corporation (NYSE: ITGR) announced plans to expand its operations in Galway, Ireland, by constructing a 60,000 square foot Medical Device Innovation and Manufacturing facility. This $30 million investment aims to meet rising demand for medical devices, particularly catheters and delivery systems. The new facility is expected to create 100-200 jobs and enhance R&D capabilities. Construction is slated to begin in 2022, with completion anticipated by late 2023. Integer currently employs around 1,300 people in Ireland, with 350 in Galway.
Integer Holdings Corporation (NYSE: ITGR) has announced a successful refinancing of its debt through the establishment of $1 billion in Senior Secured Credit Facilities. The new five-year $400 million Revolving Credit Facility, $250 million Term Loan A, and seven-year $350 million Term Loan B are expected to enhance operational flexibility and reduce borrowing costs. This transaction will improve future annualized diluted earnings per share by approximately $0.15 and extend the nearest debt maturity from 2022 to 2026.
Both Moody's and S&P upgraded the company's credit ratings to Ba3/BB- following this restructuring.
Integer Holdings Corporation (NYSE: ITGR) will showcase its innovative medical device outsourcing capabilities at the MD&M West Exposition in Anaheim, California, from August 10-12, 2021. At booth #2951, Integer will highlight its advanced Xcellion® Rechargeable Batteries, which reduce charging time by up to 70% and increase runtime by 30%. The company will also present its expanded laser cutting capabilities and comprehensive lead solutions. Integer emphasizes its commitment to quality and innovation in the medical device industry.
Integer Holdings Corporation (NYSE:ITGR) reported a strong financial performance for Q2 2021, with sales increasing by 30% to $312 million. GAAP net income rose by $29 million, reaching $29 million, while non-GAAP adjusted net income surged by 239% to $36 million. The company reduced total debt by $63 million to $669 million, achieving a leverage ratio of 3.1 times adjusted EBITDA. Looking ahead, Integer has raised its full-year sales growth outlook to 12-14% and expects adjusted operating income growth between 25-36%, signaling a robust recovery from the pandemic.
Integer Holdings Corporation (NYSE:ITGR) will announce its second quarter 2021 financial results on July 29, 2021, at 7 a.m. CT. A conference call will follow at 8 a.m. CT to discuss the results and other relevant information. Investors can participate through a domestic or international dial-in and access the webcast online. The company, a leading medical device manufacturer, aims to provide innovative technologies in various medical fields. Further information and updates can be found on their investor relations website.
Integer Holdings Corporation (NYSE:ITGR) reported its Q1 2021 results, with sales of $290 million, a 12% decline from the previous year. GAAP net income fell 31% to $22 million. Despite the pandemic's impact, sales and profits showed sequential improvement compared to Q4 2020. Integer is increasing its 2021 outlook, projecting 10%-12% sales growth, along with $90 million to $110 million in free cash flow. The company's total debt decreased by $25 million to $664 million, reflecting ongoing recovery and strategic execution.
Integer Holdings Corporation (NYSE:ITGR) announces its first quarter 2021 financial results release set for April 29, 2021, at 8 a.m. ET. The management will discuss these results in a conference call at 9 a.m. ET the same day. Investors can access the call via domestic and international dial-in numbers or through a webcast. Integer is a leading medical device outsource manufacturer, focusing on various markets including cardiac and orthopedics, and will also provide updates on additional forward-looking information during the call.